LIFECORE BIOMEDICAL, INC. Deferred Income Tax Liabilities, Net
LIFECORE BIOMEDICAL, INC. (LFCR) had Deferred Income Tax Liabilities, Net of $552.00 thousand as of 2024-11-24, per its 10-Q filed 2025-01-02.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2025-01-02
- 2024-11-24: Deferred Income Tax Liabilities, Net $552.00K.
- 2024-08-25: Deferred Income Tax Liabilities, Net $443.00K.
- 2024-05-26: Deferred Income Tax Liabilities, Net $543.00K.
- 2024-02-25: Deferred Income Tax Liabilities, Net $607.00K.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2024-11-24 | $552.00K 10-Q · filed 2025-01-02 | |
| 2024-08-25 | $443.00K 10-Q · filed 2024-10-04 | |
| 2024-05-26 | $543.00K 10-Q · filed 2025-01-02 | |
| 2024-02-25 | $607.00K 10-Q · filed 2024-08-09 | |
| 2023-11-26 | $416.00K 10-Q · filed 2024-08-09 | |
| 2023-08-27 | $456.00K 10-Q · filed 2024-08-09 | |
| 2023-05-28 | $380.00K 10-K · filed 2024-08-26 | |
| 2023-02-26 | $80.00K 10-K · filed 2024-03-20 | |
| 2022-11-27 | $10.00K 10-K · filed 2024-03-20 | |
| 2022-08-28 | $124.00K 10-K · filed 2024-03-20 | $291.00K 10-Q · filed 2022-10-07 |
| 2022-05-29 | $126.00K 10-K · filed 2024-03-20 | $232.00K 10-K · filed 2022-09-14 |
| 2022-02-27 | $796.00K 10-K · filed 2024-03-20 | $961.00K 10-Q · filed 2022-04-07 |
| 2021-11-28 | $1.20M 10-K · filed 2024-03-20 | $1.37M 10-Q · filed 2022-01-07 |
| 2021-08-29 | $3.95M 10-K · filed 2024-03-20 | $4.09M 10-Q · filed 2021-10-05 |
| 2021-05-30 | $5.97M 10-K · filed 2024-03-20 | $6.14M 10-K · filed 2021-07-29 |
| 2021-02-28 | $6.10M 10-K · filed 2024-03-20 | $6.61M 10-Q · filed 2021-04-08 |
| 2020-11-29 | $6.63M 10-K · filed 2024-03-20 | $6.75M 10-Q · filed 2021-01-07 |
| 2020-08-30 | $8.88M 10-K · filed 2024-03-20 | $9.36M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $13.59M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $11.66M 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $17.05M 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $17.69M 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $19.39M 10-K · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |